81 FR 50716 - National Cancer Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 81, Issue 148 (August 2, 2016)

Page Range		50716-50716
FR Document		2016-18164

Federal Register, Volume 81 Issue 148 (Tuesday, August 2, 2016)

[Federal Register Volume 81, Number 148 (Tuesday, August 2, 2016)]
[Notices]
[Page 50716]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-18164]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2); notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate requests 
for preclinical development resources for potential new therapeutics 
for the treatment of cancer. The outcome of the evaluation will provide 
information to internal NCI committees that will decide whether NCI 
should support requests and make available contract resources for 
development of the potential therapeutic to improve the treatment of 
various forms of cancer. The research proposals and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the proposed research projects, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; June 2016 Cycle 23 NExT SEP Committee Meeting.
    Date: August 25, 2016.
    Time: 8:30 a.m. to 4:30 p.m.
    Agenda: To evaluate the NCI Experimental Therapeutics Program 
Portfolio.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Campus Building 31, Conference Room 6C10, Bethesda, MD 20892.
Contact Persons:
    Barbara Mroczkowski, Ph.D., Executive Secretary, Discovery 
Experimental Therapeutics Program, National Cancer Institute, NIH 31 
Center Drive, Room 3A44, Bethesda, MD 20817, (301) 496-4291, 
[email protected].
    Toby Hecht, Ph.D., Executive Secretary, Development Experimental 
Therapeutics Program, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 3W110, Rockville, MD 20850, (240) 276-5683, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.3, Cancer 
Control, National Institutes of Health, HHS)

    Dated: July 27, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-18164 Filed 8-1-16; 8:45 am]
 BILLING CODE 4140-01-P

50716 Federal Register / Vol. 81, No. 148 / Tuesday, August 2, 2016 / Notices

provisions set forth in sections DEPARTMENT OF HEALTH AND Dated: July 27, 2016.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., HUMAN SERVICES Melanie J. Gray,
as amended. The grant applications and Program Analyst, Office of Federal Advisory
the discussions could disclose National Institutes of Health Committee Policy.
confidential trade secrets or commercial [FR Doc. 2016–18164 Filed 8–1–16; 8:45 am]
property such as patentable material, National Cancer Institute; Notice of
BILLING CODE 4140–01–P
and personal information concerning Closed Meeting
individuals associated with the grant
applications, the disclosure of which Pursuant to section 10(d) of the DEPARTMENT OF HEALTH AND
would constitute a clearly unwarranted Federal Advisory Committee Act, as HUMAN SERVICES
invasion of personal privacy. amended (5 U.S.C. Appendix 2); notice
is hereby given of the following National Institutes of Health
Name of Committee: National Advisory meeting.
General Medical Sciences Council. National Cancer Institute; Notice of
Date: September 15–16, 2016.
The meeting will be closed to the
public in accordance with the Meeting
Closed: September 15, 2016, 8:30 a.m. to
5:00 p.m.
provisions set forth in sections 552b(c) Pursuant to section 10(a) of the
Agenda: To review and evaluate grant (4) and 552b(c) (6), Title 5 U.S.C., as Federal Advisory Committee Act, as
applications. amended. The purpose of this meeting amended (5 U.S.C. App.), notice is
Place: National Institutes of Health, is to evaluate requests for preclinical hereby given of a meeting of the
Natcher Building, Conference Rooms E1 & development resources for potential National Cancer Institute Council of
E2, 45 Center Drive, Bethesda, MD 20892. new therapeutics for the treatment of Research Advocates.
Open: September 16, 2016, 8:30 a.m. to cancer. The outcome of the evaluation The meeting will be open to the
12:00 p.m. will provide information to internal NCI public, with attendance limited to space
Agenda: For the discussion of program committees that will decide whether available. Individuals who plan to
policies and issues; opening remarks; report NCI should support requests and make attend and need special assistance, such
of the Director, NIGMS; and other business available contract resources for as sign language interpretation or other
of the Council. development of the potential reasonable accommodations, should
Place: National Institutes of Health, therapeutic to improve the treatment of notify the Contact Person listed below
Natcher Building, Conference Rooms E1 & various forms of cancer. The research in advance of the meeting. The open
E2, 45 Center Drive, Bethesda, MD 20892. proposals and the discussions could session will be videocast and can be
Contact Person: Ann A. Hagan, Ph.D., disclose confidential trade secrets or accessed from the NIH Videocasting and
Associate Director for Extramural Activities, commercial property such as patentable Podcasting Web site (http://
NIGMS, NIH, DHHS, 45 Center Drive, Room material, and personal information videocast.nih.gov).
2AN24H, MSC6200, Bethesda, MD 20892– concerning individuals associated with
the proposed research projects, the Name of Committee: National Cancer
6200, (301) 594–4499, hagana@
Institute Council of Research Advocates.
nigms.nih.gov. disclosure of which would constitute a Date: September 26, 2016.
Any interested person may file written clearly unwarranted invasion of Time: 9:00 a.m. to 4:30 p.m.
comments with the committee by forwarding personal privacy. Agenda: Cancer Moonshot Initiative—Blue
the statement to the Contact Person listed on Name of Committee: National Cancer Ribbon Panel Recommendations; NCI’s
this notice. The statement should include the Institute Special Emphasis Panel; June 2016 Moonshot Implementation Plans and
name, address, telephone number and when Cycle 23 NExT SEP Committee Meeting. Strategies; Advocate Engagement in
applicable, the business or professional Date: August 25, 2016. Advancing the Cancer Moonshot.
affiliation of the interested person. Time: 8:30 a.m. to 4:30 p.m. Place: National Institutes of Health, 35
In the interest of security, NIH has Agenda: To evaluate the NCI Experimental Convent Drive, Building 35, Conference
instituted stringent procedures for entrance Therapeutics Program Portfolio. Rooms 620/630, Bethesda, MD 20892.
onto the NIH campus. All visitor vehicles, Place: National Institutes of Health, 9000 Contact Person: Amy Williams, NCI Office
including taxicabs, hotel, and airport shuttles Rockville Pike, Campus Building 31, of Advocacy Relations, National Cancer
Conference Room 6C10, Bethesda, MD 20892. Institute, NIH, 31 Center Drive, Building 31,
will be inspected before being allowed on
Contact Persons: Room 11A48, Bethesda, MD 20892, 301–594–
campus. Visitors will be asked to show one 3194, williaam@mail.nih.gov.
form of identification (for example, a Barbara Mroczkowski, Ph.D., Executive
Secretary, Discovery Experimental Any interested person may file written
government-issued photo ID, driver’s license,
Therapeutics Program, National Cancer comments with the committee by forwarding
or passport) and to state the purpose of their Institute, NIH 31 Center Drive, Room
visit. the statement to the Contact Person listed on
3A44, Bethesda, MD 20817, (301) 496– this notice. The statement should include the
Information is also available on the 4291, mroczkoskib@mail.nih.gov. name, address, telephone number and when
Institute’s/Center’s home page: http:// Toby Hecht, Ph.D., Executive Secretary, applicable, the business or professional
www.nigms.nih.gov/About/Council, where an Development Experimental Therapeutics affiliation of the interested person.
agenda and any additional information for Program, National Cancer Institute, NIH, In the interest of security, NIH has
the meeting will be posted when available. 9609 Medical Center Drive, Room instituted stringent procedures for entrance
(Catalogue of Federal Domestic Assistance 3W110, Rockville, MD 20850, (240) 276– onto the NIH campus. All visitor vehicles,
Program Nos. 93.859, Biomedical Research 5683, toby.hecht2@nih.gov. including taxicabs, hotel, and airport shuttles
and Research Training, National Institutes of (Catalogue of Federal Domestic Assistance will be inspected before being allowed on
Program Nos. 93.392, Cancer Construction; campus. Visitors will be asked to show one
mstockstill on DSK3G9T082PROD with NOTICES

Health, HHS)
93.393, Cancer Cause and Prevention form of identification (for example, a
Dated: July 26, 2016. Research; 93.394, Cancer Detection and government-issued photo ID, driver’s license,
Melanie J. Gray, Diagnosis Research; 93.395, Cancer or passport) and to state the purpose of their
Treatment Research; 93.396, Cancer Biology visit.
Program Analyst, Office of Federal Advisory
Research; 93.397, Cancer Centers Support; Information is also available on the
Committee Policy.
93.398, Cancer Research Manpower; 93.3, Institute’s/Center’s home page: NCRA: http://
[FR Doc. 2016–18159 Filed 8–1–16; 8:45 am] Cancer Control, National Institutes of Health, deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
BILLING CODE 4140–01–P HHS) where an agenda and any additional

VerDate Sep<11>2014 18:35 Aug 01, 2016 Jkt 238001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\02AUN1.SGM 02AUN1

Document Created: 2016-08-02 01:47:43
Document Modified: 2016-08-02 01:47:43

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		August 25, 2016.
FR Citation		81 FR 50716